Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)
PLS play an important role in increasing the accessibility of medical publications to a wide...
Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now
GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...
Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...